On June 29, 2025, JB Chemicals & Pharmaceuticals Ltd announced a share purchase agreement where Torrent Pharmaceuticals will acquire 46.39% of its equity shares from Tau Investment Holdings, along with a scheme of amalgamation between the two companies, pending regulatory approvals.